Therapeutic effects of fractionated radioimmunotherapy (RAIT) with clivatuzumab tetraxetan combined with low-dose gemcitabine (Gem) in advanced pancreatic cancer (APC) Meeting Abstract

Ocean, A. J., Guarino, M. J., Pennington, K. L. et al. (2010). Therapeutic effects of fractionated radioimmunotherapy (RAIT) with clivatuzumab tetraxetan combined with low-dose gemcitabine (Gem) in advanced pancreatic cancer (APC) . JOURNAL OF CLINICAL ONCOLOGY, 28(15), 10.1200/jco.2010.28.15_suppl.4115



cited authors

  • Ocean, A. J.; Guarino, M. J.; Pennington, K. L.; O'Neil, B. H.; Lima, C. S. Rocha; Bekali-Saab, T. S.; Gulec, S. A.; Gold, D. V.; Wegener, W. A.; Goldenberg, D. M.

fiu authors

publication date

  • 2010

published in

Digital Object Identifier (DOI)

volume

  • 28

issue

  • 15

research area

  • Oncology  Web of Science Research Area